Importantly, we further verified that SLC44A2 protein and mRNA levels were significantly increased in patients with abdominal aortic aneurysm (AAA) (Figure 1, G and H), with immunostaining indicating higher SLC44A2 levels in the media layer of human AAA aortas compared with controls (Figure 1I). The gene discussed is SLC44A2; the disease is triple-A syndrome.